1. Home
  2. DNLI vs OFG Comparison

DNLI vs OFG Comparison

Compare DNLI & OFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • OFG
  • Stock Information
  • Founded
  • DNLI 2013
  • OFG 1964
  • Country
  • DNLI United States
  • OFG United States
  • Employees
  • DNLI N/A
  • OFG N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • OFG Major Banks
  • Sector
  • DNLI Health Care
  • OFG Finance
  • Exchange
  • DNLI Nasdaq
  • OFG Nasdaq
  • Market Cap
  • DNLI 2.1B
  • OFG 2.0B
  • IPO Year
  • DNLI 2017
  • OFG N/A
  • Fundamental
  • Price
  • DNLI $15.42
  • OFG $42.65
  • Analyst Decision
  • DNLI Strong Buy
  • OFG Buy
  • Analyst Count
  • DNLI 15
  • OFG 3
  • Target Price
  • DNLI $33.50
  • OFG $46.67
  • AVG Volume (30 Days)
  • DNLI 2.1M
  • OFG 238.5K
  • Earning Date
  • DNLI 11-05-2025
  • OFG 10-22-2025
  • Dividend Yield
  • DNLI N/A
  • OFG 2.81%
  • EPS Growth
  • DNLI N/A
  • OFG 4.40
  • EPS
  • DNLI N/A
  • OFG 4.25
  • Revenue
  • DNLI N/A
  • OFG $619,470,000.00
  • Revenue This Year
  • DNLI N/A
  • OFG N/A
  • Revenue Next Year
  • DNLI $95,463.19
  • OFG $1.89
  • P/E Ratio
  • DNLI N/A
  • OFG $10.04
  • Revenue Growth
  • DNLI N/A
  • OFG N/A
  • 52 Week Low
  • DNLI $10.57
  • OFG $33.15
  • 52 Week High
  • DNLI $33.33
  • OFG $47.66
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 62.72
  • OFG 38.40
  • Support Level
  • DNLI $12.58
  • OFG $42.18
  • Resistance Level
  • DNLI $15.75
  • OFG $44.87
  • Average True Range (ATR)
  • DNLI 0.68
  • OFG 0.81
  • MACD
  • DNLI 0.24
  • OFG -0.23
  • Stochastic Oscillator
  • DNLI 89.59
  • OFG 15.67

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.

Share on Social Networks: